aTyr Pharma, Inc. (ATYR)
0.7423
-0.01
(-0.84%)
USD |
NASDAQ |
Dec 30, 16:00
0.7423
0.00 (0.00%)
After-Hours: 18:55
aTyr Pharma EPS Diluted (Quarterly): -0.265 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | 0.0175 |
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.75M |
| Revenue (Quarterly) | 0.19M |
| Total Expenses (Quarterly) | 25.93M |
| Enterprise Value | -4.681M |
| Gross Profit Margin (Quarterly) | -104.7% |
| Profit Margin (Quarterly) | -13.55K% |
| Earnings Yield | -112.4% |
| Normalized Earnings Yield | -112.45 |